Indonesia In Vitro Diagnostics (IVD) Market - By Product & Services (Reagents & Kits, Instruments, Data Management Software & Techniques), By Technology (Immunoassay, Hematology, C......linical Chemistry, Molecular Diagnostics, Coagulation & Hemostasis, Microbiology, Urinalysis, Others), By Application (Infectious Diseases, Oncology, Cardiology, Nephrology, Diabetes, Drug Monitoring & Testing, Others), By End User (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings) and Others Read more
- Healthcare
- Jun 2024
- 118
- PDF, Excel, PPT
Market Definition
In Vitro Diagnostics (IVD) describes the procedures, tests, and examinations performed on samples taken from various forms of the body fluids, such as blood, urine, tissues, and so on, outside the living organism for information on the condition of a person's health or medical situation.
Market Insights & Analysis: Indonesia in Vitro Diagnostics (IVD) Market (2024-30):
The Indonesia In Vitro Diagnostics (IVD) Market is estimated to grow at a CAGR of about 9.35% during the forecast period, i.e., 2024-30. The factors attributing to the surge in IVD are the rising incidence of chronic ailments, growing healthcare expenditure, the increasing elderly population, and budding awareness programs for early disease detection. In recent years, the lifestyle of the individuals residing in Indonesia has drastically changed and they have been increasingly consuming unhealthy food. Also, based on the statistics by the Ministry of Health, more than 95% of individuals consume unhealthy food, including packaged & junk food.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2019-22 |
| Base Year: 2023 | |
| Forecast Period: 2024-30 | |
| CAGR (2024-2030) | 9.35% |
| Region Covered | Java, Sumatra, Kalimantan (Borneo), Bali, Rest of Indonesia, |
| Key Companies Profiled | bioMérieux SA, Abbott Laboratories, PT Prodia Diagnostic Line, Fapon Biotech Inc., VIRTUE Diagnostics(Suzhou)Co., Ltd., Siemens Healthineers Indonesia, Qiagen, F. Hoffmann-La Roche AG, Sysmex Corporation, SD Biosensor |
| USD Denominations | USD Million/Billion |
Along with this, consumers have a hectic schedule, owing to which they spend fewer hours on physical exercise. As per the survey, only 20% of the individuals in Indonesia regularly engage themselves in any physical workout. Thus, less physical activity & inadequate eating habits result in higher occurrences of diseases, like obesity & overweight. More than 35.4% of individuals, i.e., around 68 million individuals are obese in Indonesia as per the Official Health Authorities. These diseases can cause harm to another vital organs of the body, therefore, the patients need to undergo immediate disease detection & prevention, supporting the In Virto Diagnostics (IVD) Market.
Additionally, the geriatric population in Indonesia is increasing due to low mortality rates. In accordance with the research by the World Bank, the death rate in the country was around 0.94%. These elderly populations are at higher risk of contracting severe health problems. As a result, they undergo regular diagnostics tests, enlarging the Indonesia In Vitro Diagnostics Market size. Also, the elderly population of the country will grow from 10% to 18% in 2040, as per the National Institutes of Health (NIH). Thus, IVD demand for quick diagnosis, monitoring, and treatment of health problems in the elderly population will increase in the forthcoming years.
Moreover, the top companies in the market are actively laying awareness programs, like the Pink Ribbon Program, to educate individuals about health problems and their detection & treatment. These campaigns would help the inhabitants focus on their health & undergo regular health checkups, uplifting the demand for In Vitro Diagnostics during 2024-2030.
- Market Segmentation
- Introduction
- Product Definition
- Research Process
- Assumption
- Executive Summary
- Indonesia In Vitro Diagnostics (IVD) Market Trends & Insights
- Indonesia In Vitro Diagnostics (IVD) Market Dynamics
- Growth Drivers
- Challenges
- Indonesia In Vitro Diagnostics (IVD) Market Hotspot & Opportunities
- Indonesia In Vitro Diagnostics (IVD) Market Supply Chain Analysis
- Indonesia In Vitro Diagnostics (IVD) Market Regulation & Policy
- Indonesia In Vitro Diagnostics (IVD) Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product & Services
- Reagents & Kits- Market Size & Forecast 2019-2030, USD Million
- Instruments- Market Size & Forecast 2019-2030, USD Million
- Data Management Software & Techniques- Market Size & Forecast 2019-2030, USD Million
- By Technology
- Immunoassay- Market Size & Forecast 2019-2030, USD Million
- Hematology- Market Size & Forecast 2019-2030, USD Million
- Clinical Chemistry- Market Size & Forecast 2019-2030, USD Million
- Molecular Diagnostics- Market Size & Forecast 2019-2030, USD Million
- Coagulation & Hemostasis- Market Size & Forecast 2019-2030, USD Million
- Microbiology- Market Size & Forecast 2019-2030, USD Million
- Urinalysis- Market Size & Forecast 2019-2030, USD Million
- Others (Chromatography, Tissue Diagnostics, etc.)- Market Size & Forecast 2019-2030, USD Million
- By Application
- Infectious Diseases- Market Size & Forecast 2019-2030, USD Million
- Oncology - Market Size & Forecast 2019-2030, USD Million
- Cardiology- Market Size & Forecast 2019-2030, USD Million
- Nephrology- Market Size & Forecast 2019-2030, USD Million
- Diabetes- Market Size & Forecast 2019-2030, USD Million
- Drug Monitoring & Testing- Market Size & Forecast 2019-2030, USD Million
- Others (Genetic Testing, Autoimmune Diseases, etc.)- Market Size & Forecast 2019-2030, USD Million
- By End User
- Hospital & Clinics- Market Size & Forecast 2019-2030, USD Million
- Diagnostic Laboratories - Market Size & Forecast 2019-2030, USD Million
- Homecare Settings- Market Size & Forecast 2019-2030, USD Million
- Others (Blood Banks, Academic Institutions, etc.)- Market Size & Forecast 2019-2030, USD Million
- By Region
- Java
- Sumatra
- Kalimantan (Borneo)
- Bali
- Rest of Indonesia
- By Company
- Competition Characteristics
- Revenue Shares
- By Product & Services
- Market Size & Analysis
- Indonesia In Vitro Diagnostics (IVD) Market Key Strategic Imperatives for Success & Growth
- Competitive Outlook
- Company Profiles
- bioMérieux SA
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Abbott Laboratories
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- PT Prodia Diagnostic Line
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Fapon Biotech Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- VIRTUE Diagnostics (Suzhou) Co. Ltd.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Siemens Healthineers Indonesia
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Qiagen
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- F. Hoffmann-La Roche AG
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Sysmex Corporation
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- SD Biosensor
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- bioMérieux SA
- Company Profiles
- Disclaimer
MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:
1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.
2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.
3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.
4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making
FILL THE FORM TO GET THE FREE SAMPLE PAGES